sulforaphane has been researched along with Dermatitis, Atopic in 3 studies
sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulforaphane was reported to ameliorate inflammatory responses." | 5.72 | Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis. ( Alyoussef, A, 2022) |
| "Sulforaphane was reported to ameliorate inflammatory responses." | 1.72 | Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis. ( Alyoussef, A, 2022) |
| "Atopic dermatitis is a chronically relapsing pruritic inflammatory skin disease." | 1.36 | Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes. ( Choi, BM; Jang, SI; Jeong, SI, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alyoussef, A | 1 |
| Wu, W | 1 |
| Peng, G | 1 |
| Yang, F | 1 |
| Zhang, Y | 1 |
| Mu, Z | 1 |
| Han, X | 1 |
| Jeong, SI | 1 |
| Choi, BM | 1 |
| Jang, SI | 1 |
3 other studies available for sulforaphane and Dermatitis, Atopic
| Article | Year |
|---|---|
Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis.
Topics: Animals; Apoptosis; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Inflammation; Isothiocyan | 2022 |
Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Dermatitis, Atopic; Disease Models, Animal; Female; | 2019 |
Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes.
Topics: Brassica; Chemokine CCL17; Chemokine CCL22; Chemokines, CC; Chemoprevention; Dermatitis, Atopic; Gen | 2010 |